(Q41742638)

8 October 2017

title

Intact, 45-kDa (membrane) form of CD23 is consistently mitogenic for normal and transformed B lymphoblasts (English)

1 reference

8 October 2017

Cairns JA

1

1 reference

8 October 2017

Gordon J

series ordinal

2

1 reference

8 October 2017

language of work or name

English

0 references

publication date

1 March 1990

1 reference

European Journal of Immunology

8 October 2017

published in

1 reference

8 October 2017

volume

20

1 reference

8 October 2017

issue

3

1 reference

8 October 2017

page(s)

539-543

1 reference

Molecular structure of human lymphocyte receptor for immunoglobulin E

8 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830200312

7 January 2021

Expression and functional role of CD23 on T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830200312

7 January 2021

From parasites to allergy: a second receptor for IgE

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830200312

7 January 2021

CD23: a multi-functional receptor/lymphokine?

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830200312

7 January 2021

Human IgE-binding factors

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830200312

7 January 2021

Human recombinant interleukin 4 induces Fc epsilon receptors (CD23) on normal human B lymphocytes.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830200312

7 January 2021

Evidence for an association between CD23 and the receptor for a low molecular weight B cell growth factor

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830200312

7 January 2021

Regulation by interleukin 2 of CD23 expression of leukemic and normal B cells: comparison with interleukin 4

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830200312

7 January 2021

Early events in Epstein-Barr virus infection provide a model for B cell activation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830200312

7 January 2021

Soluble CD23 is released by B lymphocytes cycling in response to interleukin 4 and anti-Bp50 (CDw40)

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830200312

7 January 2021

Coordinated action of IgE and a B-cell-stimulatory factor on the CD23 receptor molecule up-regulates B-lymphocyte growth

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830200312

7 January 2021

The activation antigen BLAST-2, when shed, is an autocrine BCGF for normal and transformed B cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830200312

7 January 2021

Immortalized B lymphocytes produce B-cell growth factor.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830200312

7 January 2021

Interleukin 4 and soluble CD23 as progression factors for human B lymphocytes: analysis of their interactions with agonists of the phosphoinositide "dual pathway" of signalling

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830200312

7 January 2021

Functional interaction between B cell subpopulations defined by CD23 expression

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830200312

7 January 2021

Membrane-anchored growth factors work!

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830200312

7 January 2021

Direct evidence for the presence of histidine in the active center of chymotrypsin

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830200312

7 January 2021

Antigen-driven selection of virgin and memory B cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830200312

7 January 2021

Identifiers

DOI

10.1002/EJI.1830200312

1 reference

8 October 2017

1 reference